A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621
| Autor: | Molina, Julian R., Foster, Nathan R., Reungwetwattana, Thanyanan, Nelson, Garth D., Grainger, Andrew V., Steen, Preston D., Stella, Philip J., Marks, Randolph, Wright, John, Adjei, Alex A. |
|---|---|
| Zdroj: | In Lung Cancer August 2014 85(2):245-250 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect